Indications - Ursodeoxycholic Acid is indicated for the treatment of Cholestasis (Jaundice) Viral Hepatitis Alcoholic Fatty Liver Primary Billiary Cirrhosis (PBC) Primary Sclerosing Cholangitis (PSC) Dissolution of Gallstones and Non-Alcoholic Steato Hepatitis (NASH).
Dosage & Administration - Dissolution of Gall stones: 8-12 mg/kg/day either as single night time dose or in divided doses. Primary Billiary Cirrhosis: 10-15 mg/kg/day in 2-4 divided doses. Acute Viral Hepatitis: 600 mg/day. Alcoholic Fatty Liver: 300 mg/day. Primary Sclerosing Cholangitis: 25-30 mg/kg/day. Dissolution of Gallstones and Non-Alcoholic Steato Hepatitis: 13-15 mg/kg/day.
Side Effects - Commonly reported side effects are nausea, vomiting, diarrhoea, gallstone opacilication, pruritus.
Contraindications - Non-functioning gall-bladder calcified and pigmented gallstones, inflammatory bowel disease.
Others - Pregnancy & Lactation Pregnancy category B. No evidence of harm has been reported in pregnancy. It has been effectively used for the treatment of cholestasis of pregnancy during the last trimester without any side effects. Problems have not been documented in humans regarding breast feeding.